Argyle Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Argyle Capital Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $56.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$56.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 10,767 | $9.9M |
| MCKMcKesson Corporation | 10,474 | $9.1M |
| MRKMerck & Co., Inc. | 62,816 | $7.6M |
| AMGNAMGEN INC | 19,371 | $6.8M |
| JNJJOHNSON & JOHNSON | 25,649 | $6.3M |
| BMYBRISTOL MYERS SQUIBB CO | 71,227 | $4.3M |
| PFEPFIZER INC | 151,876 | $4.3M |
| GMOptec International, Inc. | 54,819 | $4.1M |
| GEHCGE HealthCare Technologies Inc. | 22,902 | $1.6M |
| BAXBaxter International Inc. | 57,904 | $973K |
| ABBVAbbVie Inc. | 3,450 | $750K |
| TEVATeva Pharmaceutical Industries Limited | 16,200 | $488K |
| ABTABBOTT LABORATORIES | 3,905 | $401K |
| NVSNovartis AG | 2,375 | $363K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.